Tranexamic acid use in arthroscopic rotator cuff repair is an effective and safe adjunct to improve visualization: a systematic review and meta-analysis.
Epub Ahead of Print
J Shoulder Elbow Surg. 2023 01-Nov:. 10.1016/j.jse.2023.06.013Study Summary
Seven studies including 537 patients with rotator cuff tears were included in this systematic review and meta-analysis comparing tranexamic acid (TXA) versus no TXA in arthroscopic rotator cuff repair (ARCR). Pooled outcomes of interest included visual clarity, total operative time, postoperative pain scores, blood loss, shoulder swelling, and adverse events. TXA significantly improved visual clarity and reduced operative time, while no significant differences were observed in pain, blood loss, or swelling. No TXA-related adverse events were reported. Overall, TXA appears to enhance visualization and efficiency without compromising safety, suggesting it is a beneficial addition in ARCR.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
